论文信息 - Development of recurrent pseudoseptic arthritis in a patient with rheumatoid arthritis receiving TNF-alpha blocker. - 字舞流文

Development of recurrent pseudoseptic arthritis in a patient with rheumatoid arthritis receiving TNF-alpha blocker.

C. Korkmaz | T. Kaşifoğlu

[1] C. Roux,et al. Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis. , 2004, Joint, bone, spine : revue du rhumatisme.

[2] T. Doulton,et al. Antineutrophil cytoplasmic antibody-associated necrotizing crescentic glomerulonephritis in a patient receiving treatment with etanercept for severe rheumatoid arthritis. , 2004, Clinical Nephrology.

[3] S. Brantley,et al. Lung injury linked to etanercept therapy. , 2002, Chest.

[4] T. Welte,et al. Development of rheumatoid nodules during anti–tumor necrosis factor α therapy with etanercept , 2002 .

[5] Schumacher Hr,et al. Leukocytoclastic vasculitis due to etanercept. , 2000 .

[6] J. Woody,et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis , 1994, The Lancet.

[7] M. Weisman,et al. The arthritis of familial Mediterranean fever. , 1992, Seminars in arthritis and rheumatism.

[8] K. Yancey,et al. Circulating immune complexes: their immunochemistry, biology, and detection in selected dermatologic and systemic diseases. , 1984, Journal of the American Academy of Dermatology.

[9] P. R. Krey,et al. Synovial fluid leukocytosis. A study of extremes. , 1979, The American journal of medicine.